| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |